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Quantitative trait loci for variation in immune
response to a Foot-and-Mouth Disease virus
peptide
Richard J Leach1*, Susan C Craigmile1, Sara A Knott2, John L Williams1,3, Elizabeth J Glass1
Abstract
Background: Infectious disease of livestock continues to be a cause of substantial economic loss and has adverse
welfare consequences in both the developing and developed world. New solutions to control disease are needed
and research focused on the genetic loci determining variation in immune-related traits has the potential to
deliver solutions. However, identifying selectable markers and the causal genes involved in disease resistance and
vaccine response is not straightforward. The aims of this study were to locate regions of the bovine genome that
control the immune response post immunisation. 195 F2 and backcross Holstein Charolais cattle were immunised
with a 40-mer peptide derived from foot-and-mouth disease virus (FMDV). T cell and antibody (IgG1 and IgG2)
responses were measured at several time points post immunisation. All experimental animals (F0, F1 and F2,
n = 982) were genotyped with 165 microsatellite markers for the genome scan.
Results: Considerable variability in the immune responses across time was observed and sire, dam and age had
significant effects on responses at specific time points. There were significant correlations within traits across time,
and between IgG1 and IgG2 traits, also some weak correlations were detected between T cell and IgG2 responses.
The whole genome scan detected 77 quantitative trait loci (QTL), on 22 chromosomes, including clusters of QTL
on BTA 4, 5, 6, 20, 23 and 25. Two QTL reached 5% genome wide significance (on BTA 6 and 24) and one on BTA
20 reached 1% genome wide significance.
Conclusions: A proportion of the variance in the T cell and antibody response post immunisation with an FDMV
peptide has a genetic component. Even though the antigen was relatively simple, the humoral and cell mediated
responses were clearly under complex genetic control, with the majority of QTL located outside the MHC locus.
The results suggest that there may be specific genes or loci that impact on variation in both the primary and
secondary immune responses, whereas other loci may be specifically important for early or later phases of the
immune response. Future fine mapping of the QTL clusters identified has the potential to reveal the causal
variations underlying the variation in immune response observed.
Background
Infectious disease of livestock continues to be a cause of
substantial economic loss and has adverse welfare con-
sequences, even in well managed agricultural systems
[1]. In addition, even with stringent bio-security, there
are incursions of “exotic” diseases (e.g. the recent Foot-
and-Mouth Disease (FMD) outbreaks within the E.U.
[2]). Current interventions against infectious disease
include anthelminthics, antibiotics and other chemicals
as well as vaccination, although for many endemic and
exotic diseases there are limited appropriate and effec-
tive controls. Thus alternative solutions for disease con-
trol are needed. Breeding for disease resistance together
with more effective vaccines have the potential to deliver
solutions.
There is considerable variation among individuals in
the response to infectious disease and vaccination, a sig-
nificant proportion of which can be shown to be genetic
[1]. It is clear that the wide range in immune respon-
siveness and disease resistance found within livestock
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populations is controlled by many genes. Many candi-
dates genes have been identified that may influence the
immune response, including the Major Histocompatibil-
ity Complex (MHC), however, the relative contribution
of the MHC and non-MHC loci to the wide variation in
immune-related traits is only beginning to be explored.
Identifying and understanding the role of different poly-
morphic loci in immune-related traits may lead to the
identification of selectable markers for disease resis-
tance, and may also suggest new host targets to improve
vaccine efficacy.
Identifying the causal genes involved in disease resis-
tance and vaccine response is not straightforward. Phe-
notypes for these traits often require complex
measurements and are expensive to collect. Often field
data has been used which has inherent limitations and
is subject to variation caused by considerable environ-
mental influences. The actual correlates of protection
are often unknown and likely to be a complex combina-
tion of innate and acquired immunity. Many diseases,
such as mastitis can be caused by distinct pathogens
which result in different responses that are likely to be
under different genetic controls [3]. The causal patho-
gen is often not identified in field studies. In addition,
data collected may consist of single time points and
thus cannot account for variation in the kinetics of
immune responses. In order to address some of these
issues and to explore the contribution of the MHC and
other loci to variation in immune responses, a cross-
bred cattle population was immunised with a relatively
simple 40-mer peptide derived from the FMD virus
(FMDV). The peptide was used primarily as a model for
eliciting an immune response, which allowed a whole
genome scan to be conducted using microsatellite mar-
kers distributed across the bovine genome.
The FMDV peptide (FMDV15) used in this study con-
sists of two sections of the VP1 protein located on the
FMDV capsid, together encompassing the major neutra-
lising antibody sites. VP1 is one of four FMDV struc-
tural proteins (VP1-4) and contains a loop structure
that is present on the surface of the virus, which is par-
ticularly immunogenic [4]. Protection against FMD is
generally believed to relate to the levels of neutralising
antibody and has been correlated with IgG1 and IgG2
levels [5,6]. In addition it has been shown that cell
mediated responses also play a role in protection against
FMDV [7,8]. We have previously shown that there is
considerable variation in the immune response to this
and related peptides as well as variation in the protec-
tion against FMDV challenge [9,10]. Although our pre-
vious studies revealed that polymorphisms in loci within
the bovine MHC (BoLA), particularly the class II DRB3
gene, accounted for some of the variation in immune
response to FMDV [9-11], it seems likely that other
genetic factors are also important. Considerable animal
to animal variation has been reported in the context of
FMDV challenge and immunisation with a variety of
vaccine constructs including peptides. However the role
of host genetics in variation of the response to immuni-
sation has not been generally considered: there has only
been one study which suggested that host genetic fac-
tors might play a role in response to vaccination with
inactivated FMDV vaccines [12].
The work reported in this paper analysed the variabil-
ity in the kinetics of FMDV15 specific IgG1, IgG2
and T cell response during a primary and secondary
response following peptide immunisation of 195 second
generation Charolais Holstein backcross heifers. The
variations in responses to the peptide were correlated
with 165 microsatellite markers distributed across the
bovine genome to identify QTL controlling variation in
the immune response. These animals were part of a lar-
ger experimental population, the Roslin Bovine Genome
(RoBoGen) herd, and our earlier research on immune
traits in the RoBoGen herd had demonstrated that there
was a genetic component for the IgG response to a
Bovine Respiratory Syncytial Virus (BRSV) vaccine, with
a peak heritability of 0.36 [13]. Further, the T cell prolif-
erative response to a mastitis causing pathogen showed
significant sire effects [14]. In addition, meat and milk
quality QTL [15] as well as coat colour QTL [16] have
been detected in this population. In this first study to
map QTL for variation in the immune response follow-
ing a standardised controlled immunisation, regions of
the bovine genome were identified that control a pro-
portion of variance of the immune response to the
FMDV15 peptide.
Results
The 195 female F2, Holstein back-cross and Charolais
back-cross animals of the “RoBoGen” population were
immunised with the FMDV15 peptide and the resulting
antibody and T cell responses were measured across
time. The T cell responses to a T cell mitogen, Conca-
navalin A (ConA) were also measured across time. The
whole herd (males and females in the F0 to F2 genera-
tion, in total 984 animals) was genotyped with 165
microsatellite markers.
Kinetics of responses to immunisation
A humoral and cell-mediated response to the FMDV15
peptide was detected in all animals (Figure 1 and 2).
From week 2, responses were significantly different from
week 0 for anti FMDV15 peptide specific IgG1 and
IgG2, and from week 4 for the T cell proliferative
response to the FMDV15 peptide. Following a second
immunisation, the IgG1 and T cell responses to the
FMDV peptide increased significantly (p < 0.01). The
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mean values for the IgG1 responses (Standard Deviation,
SD) for weeks 0, 1, 2, 4, 8, 10 and AUC (area under the
curve, to provide a single trait that reflected the overall
response, see methods.) were 1.2 (1.4), 1.3 (1.4), 69.7
(66.1), 167 (144.4), 291.7 (269.2), 176.1 (141.6) and
1658.4 (1381.3) μg/ml respectively. The IgG2 responses
for weeks 0, 1, 2, 4, 8, 10 and AUC were 0.01 (0.04),
0.01 (0.05), 5.6 (8.8), 13.1 (17.3), 24.3 (64.7), 23.5 (71.7)
and 144.4 (302.3) μg/ml respectively. The means for the
T cell stimulation index of response to the FMDV
peptide at weeks 0, 4, 8, 10 and AUC were 1.131 (0.58),
1.8 (1.5), 2.6 (3.7), 4.6 (14.6), 21.9 (27.3) SI. Correlations
between the time points and between traits (Additional
File 1) revealed that there was a high correlation
between the antibody levels at week 0 and 1 (r2 = 0.88,
p < 0.0001 for IgG1; r2 = 0.61, p < 0.0001 for IgG2).
Most of the significant correlations were positive. The
early IgG1 response (week 2) correlated with later
responses at week 4 (r2 = 0.31, p < 0.0001) and 8 (r2 =
0.26, p < 0.0001) and the pre-boost response at week 4
correlated with the post-boost response at week 10
Figure 1 Variation in IgG isotype responses. FMDV15 peptide
specific IgG1 (A) and IgG2 (B) levels following immunisation at
weeks 0 and 6 of 195 female cattle. Median (central horizontal line),
quartiles (outer horizontal lines) and range (outer vertical lines)
shown. Over 90% of the animals at week 0 and week 1 showed a
very low IgG2 response. Thus the median and quartiles tend to zero
at these weeks. All data is log10 transformed.
Figure 2 Variation in T cell proliferation. Box plots depicting
T cell proliferation (stimulation index) across time following
immunisation with FMDV peptide. 2 ug/ml FMDV15 peptide (A),
and 10 ug/ml Con A (B). Median (central horizontal line), quartiles
(outer horizontal lines) and range (outer vertical lines) shown. FMDV
peptide administered at week 0 and 6. All data has been log10
transformed.
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(r2 = 0.69, p < 0.0001). In addition responses at weeks 8
and 10 were also highly correlated (r2 = 0.38, p < 0.0001).
The IgG2 response showed similar correlations in so far
that earlier responses correlated with later responses,
with the strongest correlations (r2 > 0.4, p < 0.0001) seen
between weeks 2 and 4, weeks 4 and 8, and weeks 8 and
10. Similarly, the pre-boost T cell response to the
FMDV15 peptide at week 4 correlated with the post-
boost response at weeks 8 and 10 (r2 = 0.224 and r2 =
0.155; p < 0.0001), with the highest correlation between
weeks 8 and 10 (r2 = 0.57, p < 0.0001). The ConA T cell
responses correlated moderately across all time points
with r2 > 0.2, except between weeks 0 and 4 which had
an r2 = 0.12 (all correlations had a significance of at least
p < 0.0001).
Furthermore, correlations were found between some
of the different trait types (Additional File 1). The IgG1
and IgG2 responses were moderately correlated at the
same weeks from 2 to 10 (r2 at least 0.14, all values p <
0.0001). No significant correlations were seen between
the anti FMDV15 T cell response and IgG1 responses.
However, some weakly significant correlations were seen
between the T cell response and the IgG2 response,
with one highly significant correlation at week 8 (r2 =
0.14, p < 0.0001). In addition the T cell response to the
FMDV peptide correlated with the ConA response, with
the strongest correlations seen at the same weeks 4, 8
and 10 (r2 > 0.43, p < 0.0002).
Analysis of fixed and random effects
As reported above considerable variation was observed
between animals for all three immune parameters, IgG1,
IgG2 levels and T cell proliferation (Figure 1 and 2A).
The greatest variation among animals was seen in the
IgG2 response at week 8, which was significantly greater
than the variation seen at any other time point through-
out the IgG1 or IgG2 response (p < 0.001). In addition,
the proliferative response to ConA varied among ani-
mals and across time points following immunisation
(Figure 2B). The T cell proliferative response to the
FMDV15 peptide (Figure 2) showed less variation
among animals across the time points than the T cell
proliferation to Con A. The skew (change in low to high
responses, Figure 2) in the T cell response to the
FMDV15 peptide changed over time, from a negative
skew to a positive skew as more animals made a
response in the later time points.
When week was included as an interaction within the
REML model (data not shown), cohort was significant
for both the T cell response to the FMDV peptide (p <
0.001) and the T cell response to Con A (p < 0.001).
Further, weight at vaccination was found to be signifi-
cant for both T cell response to the FMDV peptide (p =
0.015) and the T cell response to Con A (p = 0.019),
with lighter animals having higher T cell responses. Age
at initial vaccination was only significant for the IgG2
responses to the FMDV peptide (p = 0.005), with older
animals having higher IgG2 levels.
When the traits were analysed week by week (Addi-
tional File 2) cohort was significant throughout for each
trait, with the exception of the IgG2 response, for which
cohort was only significant twice throughout the time
course. The effects of age and weight also differed: age
at vaccination was significant from weeks 0 and 1 for
IgG1 responses and only at week 1 for IgG2 responses.
No significant age effect was found for either of the
T cell proliferation responses. Weight was found to be
significant for T cell proliferation to the FMDV peptide
at week 8 post vaccination (p = 0.049). Line (F2, CB1,
and HB1) was not a significant factor for any traits.
Sire and dam effects varied throughout the study
(Additional File 2). However, some sires were nested
within lines. No significant sire effects were seen for the
IgG1 responses. Some dam effects were detected; how-
ever most dams only had one calf. The IgG2 response
had no significant dam effects whereas sire was signifi-
cant from weeks 2 to 10 inclusive (all p < 0.05, with
weeks 8 and 10 being p < 0.005). The T cell prolifera-
tion responses showed no significance association with
sire or dam, with the one exception of a dam effect at
week 0 for the Con A response (p = 0.005).
Overall QTL Results
A total of 77 QTL were identified for all 4 of the trait
types (IgG1 and IgG2 concentrations; T cell prolifera-
tion to Con A and FMDV15 peptide) studied (Table 1).
Of these, 11 were above the 1% chromosome signifi-
cance threshold (but below the genome wide 5% signifi-
cance threshold), 2 were above the genome wide 5%
significance threshold (but below the genome wide 1%
significance threshold) and 1 was above the 1% genome
wide significance threshold. The initial linkage associa-
tion analysis revealed 54 QTL, and a further 23 were
located by fitting each QTL as a background effect. The
average (mean) F-value for QTL above the 1% chromo-
some threshold was 6.40 (standard deviation (SD) 0.38),
the average F-value for QTL above the 5% chromosome
threshold was 4.52 (SD 0.38). The majority of the confi-
dence intervals (CI) (Additional File 3) were large with
an average of 72.8 cM calculated across all QTL above
the 5% chromosome wide significance level. The CI
reflected the estimated QTL effect size, the number of
animals used in the study and the density of the mar-
kers used. The average phenotypic variance (corrected
for fixed effects) accounted for in this study across all
QTL above the 5% chromosome wide threshold was
5.8%. A total of 46 significant additive effects were
found (Table 1). In 18 of these instances the Charolais
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allele increased the traits value, whereas the remaining
28, the Holstein allele increased the traits value. Domi-
nance effects were significant in 42 QTL, showing if the
alleles were dominant or recessive (see methods).
Each of the four trait types (IgG1 response; IgG 2
response; T cell response to FMDV and T cell response
to Con A), were clearly under polygenic control (Table 1
and 2), and no QTL were found that controlled all traits.
Of the 77 QTL detected, the majority (51) played a role
in determining the FMDV15 specific antibody responses,
whereas fewer (26) controlled the T cell response to
FMDV15 and Con A.
With few exceptions, different QTL were detected at
different time points. The majority of QTL appeared to
be specific for a given trait type or for early or late time
Table 1 All QTL located in this study
Chr1 Trait2 cM3 F4 a5 d5 Var%6
2 IgG1_week_10 38 5.60 -0.21** 0.26** 5.71
3 IgG2_week_2 58 5.93 0.66** 0.40 6.03
4 IgG1_week_1 31 5.35 -0.63** 0.34 5.46
4 IgG1_week_8 20 5.17 0.12 0.17** 1.18
4 IgG1_week_10 27 4.92 0.23 -0.47* 5.05
4 IgG1_AUC 28 6.37* 0.11 -0.43* 6.64
4 SI_FMDV_Week_0 67 4.79 0.00 -0.14** 4.92
5 SI_CA_Week_0 68 8.10* -0.13* 0.24** 8.05
5 SI_CA_Week_0 100 5.76 0.22** -0.14 6.11
5 SI_CA_Week_10 76 5.26 -0.05 0.23** 5.38
5 SI_CA_10 ug_AUC 69 5.89 -0.06 0.17** 6.04
6 SI_CA_Week_0 30 8.69** 0.26*** 0.08 8.59
6 SI_FMDV_Week_8 59 6.49 0.14** -0.08 6.56
6 SI_FMDV_Week_8 133 7.35* 0.04 -0.20*** 7.51
6 SI_FMDV_Week_10 3 6.61 0.12** -0.15* 6.67
6 SI_FMDV_AUC 2 7.91* 0.10*** -0.07 7.96
6 SI_FMDV_AUC 133 6.21 0.03 -0.13** 6.56
7 IgG2_week_8 0 6.24 -0.85*** 0.13 6.58
7 SI_CA_Week_10 0 4.89 0.05 0.28** 5.02
7 SI_FMDV_Week_4 54 5.45 -0.11** -0.09 5.62
9 IgG1_week_0 40 5.29 -0.2948* 0.35 5.41
9 SI_FMDV_Week_10 63 4.92 0.05 -0.23** 5.05
11 IgG1_week_0 0 5.26 0.25 -0.61* 5.38
12 IgG2_week_8 17 5.44 -0.03 1.24*** 5.56
13 IgG1_week_1 0 5.08 0.04 -0.54** 5.20
14 IgG2_week_0 2 4.85 0.12 -0.28** 4.98
15 IgG2_week_8 13 5.16 -0.08 1.03** 5.28
15 IgG2_AUC 27 5.39 -0.08 0.67** 5.51
16 IgG2_week_2 76 6.51 -0.71*** -0.16 6.58
16 SI_FMDV_AUC 64 4.42 -0.06* -0.07* 4.61
18 SI_CA_Week_10 22 7.02* -0.20*** 0.10 7.06
18 IgG2_week_1 57 5.23 -0.10 0.34** 5.40
19 IgG2_week_2 28 4.93 -0.50* -0.62* 5.06
19 IgG2_week_4 34 5.64 -0.73*** -0.32 5.75
19 IgG2_week_8 50 5.28 -0.81** -0.25 5.63
19 SI_CA_Week_8 32 8.57* 0.25*** -0.07 8.48
19 SI_CA_Week_10 32 4.54 0.15* -0.13 4.67
19 SI_CA_10 ug_AUC 28 4.42 0.13** -0.01 4.61
20 IgG1_week_2 28 4.74 -0.03 0.48** 4.87
20 IgG1_week_4 36 7.86* 0.20** 0.35** 7.83
20 IgG1_week_8 9 6.49* 0.19 0.64** 6.56
20 IgG1_week_10 23 5.37 0.09 0.38** 5.48
20 IgG1_AUC 20 10.07*** 0.12 0.39*** 9.82
20 IgG2_week_4 32 7.48 0.52** 0.65* 7.48
20 IgG2_week_8 25 8.46 0.76** 0.87* 8.38
20 IgG2_week_10 31 6.23 0.33 0.82** 6.31
20 IgG2_AUC 31 8.5* 0.40** 0.67** 8.41
20 SI_FMDV_Week_0 61 7.95* 0.05 -0.18*** 7.92
21 IgG1_week_2 69 4.96 -0.22* 0.38* 5.09
21 SI_CA_10 ug_AUC 84 4.10 -0.14** -0.01 4.28
23 IgG1_week_0 78 5.11 -0.19 -0.54** 5.24
Table 1 All QTL located in this study (Continued)
23 IgG1_week_1 65 5.83 -0.13 -0.87*** 5.92
23 IgG1_week_2 39 4.16 0.37 -0.53 4.31
23 IgG1_week_10 18 5.25 0.37** 0.03 5.37
23 IgG1_AUC 18 5.34 0.29** 0.06 5.46
23 IgG2_week_4 0 5.45 0.63** -0.18 5.57
23 IgG2_week_8 5 5.85 0.88*** -0.18 5.94
23 IgG2_week_10 33 4.08 1.02** 0.77 4.23
23 IgG2_AUC 6 6.61* 0.66*** -0.18 6.67
24 IgG1_week_8 35 7.83** 0.58*** 0.32 7.80
24 IgG1_week_10 33 4.18 0.27** 0.06 4.32
24 IgG1_AUC 33 6.23 0.25*** 0.12 6.31
24 IgG2_week_10 21 5.09 0.69** 0.61 5.32
24 SI_CA_Week_4 34 5.46 -0.05 0.28** 5.63
25 IgG1_week_0 0 4.48 0.34* 0.28 4.62
25 IgG1_week_1 0 4.88 0.29* 0.35* 5.01
25 IgG1_week_2 33 4.42 0.05 -0.35** 4.66
25 IgG2_week_1 15 4.48 0.18** -0.11 4.62
25 IgG2_week_2 34 4.65 -0.14 -0.73** 4.78
25 IgG2_week_4 34 4.85 -0.14 -0.70** 4.98
25 IgG2_AUC 34 5.28 -0.04 -0.62** 5.40
25 SI_CA_Week_10 17 5.79 -0.11* 0.19** 5.89
26 IgG1_week_1 21 4.90 -0.30* 0.35 5.25
27 IgG2_week_4 7 4.61 -0.57** -0.33 4.75
29 SI_CA_Week_0 0 5.34 0.15** -0.11 5.69
29 SI_FMDV_Week_8 7 4.90 -0.10* 0.12 5.03
29 SI_FMDV_Week_10 0 4.38 -0.11** 0.08 4.61
1. Chr: the chromosome number of the QTL. Underlined if 2 QTL model.
2. Trait: each trait is shown as follows: trait type (IgG1; IgG2; SI_FMDV = T cell
proliferation to the FMDV peptide; SI_CA = T cell proliferation to Concanavalin A),
followed by week post immunisation.
3. cM: the position the QTL is on the chromosome, in centiMorgans.
4. F: the F-statistic for each QTL. Significance level: all are at least 5%
chromosome wide, * = p < 1% chromosome wide, **= p < 5% genome wide
and ***= p < 1% genome wide.
5. “a” and “d” are the additive and dominance effect, respectively, of each
QTL, * = p < 5%, **= p < 1% and ***= p < 0.01%.
6. Var%: the phenotypic variance explained by the QTL.
Clusters of related traits have been boxed, 6 in total.
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points, suggesting that T cell and antibody response
must be, in the main, under the control of different genes
(Table 2). A few chromosomal regions appeared to con-
trol more than one type of response in particular QTL
on BTA 20 (Figure 3 and Table 2), BTA 23 (Figure 4)
and BTA 25 (all 3 BTA shown in Table 1) impacted on
the greatest number of traits (9, 9 and 7 respectively).
QTL on BTA 4, 19, 20 and 23 all played a role in both
the primary and secondary responses, whereas QTL on
BTA 20, 23, 24 and 25 all affected the FMDV15 specific
IgG1 and IgG2 at several time points, although the QTL
located on BTA 25 specifically influenced the primary
IgG1 and IgG2 responses and not the secondary antibody
responses. In contrast the QTL on BTA 24 was detected
for the secondary responses of both antibody isotypes but
not the primary responses. Interestingly, the QTL
on BTA 23 influenced earlier time points for the
IgG1 response, and not the IgG2 response (Table 1 and
Figure 4). The QTL with highest additive effect (p < 0.01)
was identified on BTA 23 associated with the IgG2
response at week 10, where the additive effect of the Hol-
stein allele was an increase of 10.5 μg/ml. IgG2 responses
in week 8 on BTA 12 and 15, both showed large domi-
nance effects of 17.4 μg/ml and 11.0 μg/ml (p < 0.01 and
p < 0.1, respectively).
Very little overlap was observed in the chromosomal
regions controlling the T cell response to the FMDV 15
immunising antigen, and the T cell response to the
T cell mitogen, ConA, with the exception of QTL on
BTA 6 and BTA 29. In addition, very little overlap was
seen between QTL controlling the T cell responses and
the antibody responses, with the exception of the QTL
on BTA 20, which appeared to play a role at several
time points for both antibody isotypes as well as the
T cell response at the initial immunisation time point.
Indeed the QTL with the highest F value (10.07; 1%
genome wide significance) in the study was for the AUC
for the anti-FMDV15 IgG1 response, and was located
on BTA 20, where the clusters of QTL controlling IgG1
and IgG2 traits are also located. This QTL alone
accounted for 9.8% of the variance for the overall IgG1
response. Other highly significant QTL included a QTL
on BTA 24 for the IgG1 response at week 8 and T cell
response to Con A at initial immunisation on BTA 6
(both 5% genome wide significance).
2 QTL Model
Following the initial analysis, each QTL was added as
background effect and 2 QTL models were run. This
analysis identified 3 significant 2 QTL models (Table 1).
These included the T cell response to Con A at Week 0
on BTA 5; T cell responses to the FMDV15 peptide at
Week 8 (Figure 5) and AUC, both on BTA 6. Each of
these pairs of QTL on single chromosomes had at least
two markers separating them.
Clusters
Although a few chromosomes (BTA 2, 3, 11, 12, 13, 14,
26 and 27) only appeared to have QTL affecting an indi-
vidual immune-related trait at one time point, several
chromosomes had QTL affecting a trait across time. All
chromosomes with greater than 3 QTL for the same
trait across time (i.e. IgG1 weeks: 0, 2 and 4) with over-
lapping CI are shown with outline boxes in Table 1 and
are referred to as “clusters”. There were 6 such clusters
located on BTA 4, 5, 6, 20, 23 and 25 (Table 1; Figure 3,
4 and Table 2). The most significant QTL in the study
was located within the clusters of QTL for IgG1 and
IgG2 responses on BTA 20 (Table 1). The greatest phe-
notypic variation explained within this cluster for the
IgG1 response was 9.82% and 8.41% for the IgG2
response. This region also influenced the T cell response
Table 2 Chromosomal positions of all QTL
BTA number3
Trait1 Week2 9 11 23 25 13 26 4 21 20 24 2
IgG1 0 x4 x x x
1 x x x x x
2 x x x x
4 x
8 x x x
10 x x x x x
14 18 25 3 16 19 27 20 23 7 12 15 24
IgG2 0 x
1 x x
2 x x x x
4 x x x x x
8 x x x x x x
10 x x x
4 20 6 7 29 9
T-cell
FMDV
0 x x x
4 x
8 xx x
10 x x x
29 6 5 24 19 25 7 18
T-cell
ConA
0 x x xx
4 x
8 x
10 x x x x x
1. Trait = immune response type to the FMDV15 peptide.
2. Week post immunisation.
3. Bos Taurus Autosome (BTA) number.
4. Each ‘X’ represents the presence of a QTL, ‘XX’ represents 2 QTL. All are at
least 5% chromosome wide significant.
(AUC results are omitted as they are representative of the overall response
across time.)
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BTA 23: Multiple QTL 
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Figure 4 BTA20: Significant QTL. F-statistic profile for IgG1 and IgG2 responses (AUC = area under curve) elicited by FMDV15 peptide, located
on chromosome 20. The dashed horizontal line represents the threshold of the 1% genome wide significance (F = 9.94). The dot-dashed line
represents the threshold of the 5% genome wide significance (F = 8.10). Traits are described as Table 1.
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Figure 3 BTA23: Significant QTL. F-statistic profile and support intervals for IgG1 and IgG2 responses (AUC = area under curve) elicited by
FMDV15 peptide, located on chromosome 23. The constant horizontal line represents the threshold of the 1% chromosome wide significance
(F = 5.90). Traits are described as Table 1.
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to FMDV15 at the time of immunisation. BTA 23 con-
tained two QTL clusters for IgG1 and IgG2 responses.
All of the clusters, with the exceptions of the clusters on
BTA 4 and BTA 5, had additive effects showing Holstein
alleles increased the phenotype in a favourable direction.
Discussion
This study has revealed that both the humoral and cell
mediated immune response to a relatively simple
40-mer peptide are under the control of a considerable
number of chromosomal loci. The phenotypes described
in the present study were all obtained using a standar-
dised experimental protocol and a uniform dose of a
specific antigen. This study is also unique in that it was
possible to measure both a primary and secondary
immune response across time and thus detect QTL that
influenced different phases of the immune response.
These considerations may, at least in part, explain the
large number of QTL detected. The outcomes of disease
resistance or vaccine induced protection are likely to
depend on a range of immune-related mechanisms. The
present study concentrated on some of these underlying
traits, namely antibody and cell mediated immune
responses. Although these have been shown to play a
role in host protection against FMDV [5-8], considerable
animal-to-animal variation is observed and no immuno-
logical parameter correlates entirely with protection.
Our study suggests that host genetics may be an impor-
tant factor underpinning these discrepancies and further
research on the relationships between host genotypes,
accurately determined phenotypes in experimental
studies, such as ours, and protection and disease out-
come as measured in field studies are clearly warranted.
Unexpectedly, a number of QTL were detected for the
0 time point for both antibody and T cell proliferation.
It is difficult to interpret these results as the animals
were naïve to the FMDV peptide. In a previous study it
was noted that the control values for T cell proliferation
were under genetic control [14], and thus the QTL for
the T cell proliferation to the FMDV peptide at time 0,
may be related to the inherent ability of T cells in cul-
ture to proliferate. Measurements of cellular immunity
are inherently more difficult to conduct than measure-
ments of humoral immunity, partly because cell based
assays have to be conducted with fresh cells. Generally
T cell proliferation is measured by purifying peripheral
blood mononuclear cells (PBMC) and measuring the
response at day 5 of culture [17]. For the work reported
here a high-throughput system had to be devised to
measure the cellular immune response to the FMDV
peptide in large numbers of animals, which involved
whole blood cultured for 6 days which may have
resulted in greater variation compared to the prolifera-
tion response by purified peripheral blood mononuclear
cells. A further factor that may explain the high 0 time
values is that the FMDV peptide contains an “RGD”
motif which enables the FMDV virus to bind to integ-
rins on the cell surface to facilitate virus entry [18].
Fluorescently labelled FMDV peptide has been shown to
bind to a wide variety of cells (Glass, unpublished obser-
vation) potentially through integrin binding. In addition
it is possible that there are soluble molecules in serum
BTA 6: 2 QTL for T cell response to FMDV15 peptide 8 weeks post 
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Figure 5 BTA6: 2 Significant QTL. F-statistic profiles for two QTL on BTA6 for the T cell proliferation to FMDV15 peptide at week 8. The peak of
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that bind to the “RGD” motif in the peptide coated on
the ELISA plate: this may have caused a “background”
non-FMDV specific binding. Thus possibly the QTL
might be reflect variants in integrin molecules. The
genes for the main integrin receptor by FMDV for entry
into cells are ITGAV and ITGB6 on BTA 2 (unpub-
lished observations) which does not appear to influence
the values for the 0 and 1 time points. Nonetheless, the
values seen at time 0, for both antibody and prolifera-
tion, are orders of magnitude lower than the adaptive
immune responses generated to the peptide, and for the
main part the time 0 values did not correlate with the
responses observed at later time points.
One of the key genome regions controlling immune
responses is the MHC locus [19]. Our study provides
further support for the relative role of the MHC and
adds further confidence to the QTL discovered. How-
ever the current study has shown that even the response
to a relatively simple antigen is complex and controlled
by many loci.
Throughout the study the cohort of the animals was
significant (the cohorts correspond to the year of birth
of the animals). Environmental sources of variation were
minimised as far as possible, including husbandry, food,
food supplements and farm. Cohort was, however,
found to be significant in the same herd for response to
a BRSV vaccine [13], a mastitis causing pathogen [14] as
well as in meat and milk traits [15]. Weight and age at
vaccination were also significant throughout the study.
Lighter animals had higher T cell responses in compari-
son to heavier animals, suggesting that breeding for hea-
vier animals may have a detrimental effect on an
animal’s ability to fight infection. Linear regression of
IgG1 AUC against age showed that the older animals
had significantly higher immune responses (data not
shown). This suggests that even in older animals the
immune system may still be developing, although possi-
bly these changes may be hormonally related as all the
animals in this study were female and there are clear
gender and hormone related differences in immunity
[20]. The increase in response is not a result of exposure
to FMDV, unlike the situation for endemic pathogens
such as BRSV which could conceivably influence the
response to BRSV derived antibody. Age was also a sig-
nificant factor in the IgG1 and IgG2 response to a
BRSV vaccine in this experimental herd [13]. However,
the animals were much younger than in the present
study.
Significant line effects have previously been shown for
response to a BRSV vaccination [13], but not response
to Staph. aureus [14]. The current study also did not
find any line effects. It is possible that the founder
breeds, Holstein and Charolais, have similar immune
responses to the FMDV15 peptide, although this has not
been formally tested. Villa-Angulo et al [21] have shown
that Holstein and Charolais cattle breeds have highly
correlated haplotype blocks, thus it is feasible that the
similar immune response seen in this study is due to
the two breeds being highly related. However, within
the QTL study 6 of the 8 QTL clusters had increased
phenotypes resulting from Holstein alleles, indicating
that there might be breed differences in the pathways
used to initiate and maintain a response to the FMDV15
peptide. Sire effects have previously been demonstrated
in this herd, both in the immune response to a BRSV
vaccine [13] and also to Staph. aureus [14]. In the pre-
sent study sire effects were only significant for the IgG2
response to the FMDV15 peptide. Dam was only spora-
dically significant without any obvious patterns to
explain the weeks it appeared significant. However, the
number of calves per dam was small, so it is unlikely
that enough statistical power existed to detect dam
effects.
The immune response is a complex trait and across
time different factors will play a role in affecting the
level of a particular response, for example, the initiation
of an immune response involves components of innate
immunity such as macrophages and dendritic cells
which signal alarm to the adaptive immune system
which takes longer to respond to immunisation and
invasion by pathogens. In addition, the primary response
is under the influence of different factors from the sec-
ondary response, which is generally of greater magni-
tude and longer duration. Nonetheless, several QTL
which influenced the same traits were detected across
time, suggesting that there may be gene(s) that impact
on both the primary and secondary responses. Thus
genetic factors may underlie some of the significant cor-
relations across time and within traits (Additional File
1). The highest correlations observed were within traits
and several chromosomes contain QTL for the same
trait at different time points. This suggests that
responses at early time points can be predictive of those
at later time points, information that may be useful in
QTL studies where it is not possible to make serial mea-
surements. However, the data presented here also sug-
gests that there are several loci which have more
specific effects either at single time points or on specific
immune traits, which may reflect the different cell types
and factors operating at different phases of the immune
response.
Inter-trait correlations were observed between the
IgG1 and IgG2 responses (Additional File 1), although
for the most part the QTL controlling these traits did
not coincide on the same chromosomes, with the nota-
ble exceptions of the QTL on BTA 23, the 95% confi-
dence interval of which harboured the BoLA locus, and
BTA 20. Both of these chromosomes may have genes
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that control both types of antibody response across
time. All animals had considerably higher IgG1 than
IgG2 responses, with a proportion having no detectable
IgG2 response at any time point [11]. The QTL with
the greatest influence on the overall IgG1 responses
were BTA 4, 20, 23 and 24 which together accounted
for over 25% of the variance. Apart from BTA 20 and
23, two different regions on BTA 15 and 25 were also
linked to the overall IgG2 response, and these 4 regions
also accounted for over 25% of the variance for overall
IgG2 response. In cattle it appears that IgG1 is asso-
ciated with type 2 T cell responses and IgG2 with type
1 [22]. Thus regions controlling the differing responses
may harbour genes that influence the balance between
Th1 and Th2 responses; plausible candidate genes under
QTL include IL18 on BTA 15 and IL4R on BTA 25.
The T cell responses to the ConA mitogen and the
FMDV15 peptide were also correlated, in particular the
responses at the same time points. This was unexpected
as immunisation with the FMDV15 peptide should not
influence the responses to ConA, as the latter is a T cell
mitogen. One possible explanation may be that the
T cells stimulated by the FMDV peptide become more
responsive to T cell mitogens, indeed proliferation was
observed in the presence of medium alone and increased
across time, suggesting that immunisation may have
activated the overall T cell population. However, with
the exception of BTA 6, 7 and 29, no co-incident QTL
for T cell response to ConA and FMDV15 were
observed. Further, as no correlations were detected in
the responses of the T cell proliferation compared to
IgG levels, there seems not to have been a cellular or
humoral bias in this study.
Interestingly, every QTL cluster, with the exception of
the cluster on BTA 25, contained at least one QTL
above the 1% chromosome-wide significance level. Thus
the clusters appear to highlight regions of the bovine
genome that are highly associated with the immune
response to the FMDV15 peptide. The two clusters con-
taining the QTL associated with the greatest number of
traits were located on BTA 20 (Table 1; Figure 3) and
23 (Table 1; Figure 4; both included in Table 2). The
cluster located on the telomeric region of chromosome
20 has highly significant dominant effects, suggesting
that over-dominance may have a role to play in these
QTL. Further, this region has also been associated with
a number of diseases, including resistance to Mycobac-
terium avium ssp Paratuberculosis the causative bacter-
ium of Johne’s disease [23], bovine keratoconjunctivitis
(pinkeye) [24] and respiratory disease and pododermati-
tis (footrot) [25]. Taken together with the data presented
here this suggests that gene(s) located in this region may
control the response to several bacterial and viral patho-
gens, possibly by influencing antibody production. The
current data suggest that the gene(s) underlying this
QTL impact on the antibody responses across time.
Further research to identify the gene(s) underlying these
associations is warranted as they may represent genes
for “generalised immune competence” or resistance to a
broad range of pathogens.
The QTL cluster located on BTA 23 includes the
bovine MHC (BoLA) region [26]. However, few markers
were spaced across BTA 23, and the QTL CIs covered
the whole of BTA 23. Our previously study using the
same population of animals showed that the highly poly-
morphic BoLA DRB3 gene is significantly associated
with the response to FMDV15 [11] in this herd and ear-
lier studies have indicated that DRB3 polymorphisms
are also linked to protection against viral challenge fol-
lowing immunisation with FMDV15 and similar pep-
tides [9]. It is therefore likely that the causal genes
underlying the part of the BTA 23 QTL effect may be
coded for within the BoLA region. However, there are
at least 154 predicted genes in this region [27], which
may make it difficult to identify the causative mutations.
Other QTL studies conducted on this herd, for traits
such as meat quality [15], coat colour [16] and tempera-
ment [28] also have QTL which overlap (+/- 10cM)
with QTL discovered in the current study. QTL for
meat quality overlapped with 6 QTL in the current
study (BTA: 6, 13, 15, 16, 19 and 25), QTL for tempera-
ment also had 6 overlapping QTL (BTA: 4, 7, 9, 18, 20
and 25) with the same QTL on BTA 25 appearing in all
3 studies, suggesting a major gene/pathway may exist
below these QTL which affects, not only the immune
response, but the quality of meat and the temperament
of the animals. Only one QTL overlapped with QTL
from the coat colour study, located on BTA 5. No clear
pattern appears in the overlapping QTL, with exception
for the QTL on BTA 25.
The QTL cluster on BTA 6 overlaps with a QTL that
is associated with a mastitis related trait [29]. Recently
Jann et al [30] have identified the toll like receptor
(TLR) cluster of TLR1, 6 and 10 genes as the most likely
candidate genes within this region on BTA 6. TLRs play
an important role in both innate and adaptive immunity
[31]. Villa-Angulo et al [21] demonstrated that BTA 6
has haplotype blocks that are similar (r2 = 0.61) between
the breeds used in the current study, thus the genes in
both breeds are likely to be in the same regions and
orders in the cluster of TLR 1, 6 and 10.
Conclusion
Although a variety of traits in diseased and clinically
healthy animals have been used to identify QTL in live-
stock [31]. This study focused specifically on immune
responses across time following a specific immunisation
procedure to identify QTL controlling defined immune
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responses. The density of markers and numbers of ani-
mals used is not sufficient to fine map the QTL regions
identified, however, further work is warranted especially
to refine the QTL clusters, which appear to be the most
promising regions. With the availability of the bovine
genome sequence [27], the bovine HapMap [32] and
dense bovine SNP arrays [33] unprecedented opportu-
nities are now available to identify genes and pathways
underlying immune-related traits. The QTL discovered
in this study may ultimately reveal novel targets for
both the selection of disease resistant livestock as well
as for the improvement of vaccines in their efficacy.
Methods
Animals
A total of 501 second generation cross bred animals
were produced in the Roslin Bovine Genome (RoBoGen)
herd. Pure-bred Charolais sires (8) were mated to Hol-
stein dams (221) to produce the F1 (8 male, 134 female)
and 8 F1 sires were mated to F1 heifers to create the F2
group within the second generation. The founder Char-
olais sires were mated to F1 heifers to produce a Charo-
lais backcross (CB1) and F1 sires were mated to pure
bred Holstein heifers to create a Holstein backcross
(HB1). Immune response measurements were collected
from the 195 second generation cross heifers (121 from
the F2, 43 from the HB1 and 31 from CB1). All female
calves were weaned by 36 h, segregated from the rest of
the herd and raised indoors, initially on milk-replacer
then weaned early onto a propriety compound diet. The
age of the first immunisation with the FMDV15 peptide
ranged from 469-609 days.
Immunisation and sampling
The FMDV15 peptide was chemically synthesized using
an ABI 431A peptide synthesiser with FMOC chemistry.
Following deprotection and cleavage, it was purified by
preparative reverse phase HPLC (Beckman Coulter Sys-
tem Gold HPLC using a Phenomenex Luna C18 col-
umn). The peptide consisted of two separate regions
(residues 141 to 158 and 200 to 213) of the virus coat
protein (VP1) from the O1 Kaufbeuren strain of foot-
and-mouth disease virus [4]. The female F2 and back-
cross heifers were immunised subcutaneously with 1 mg
FMDV15 peptide/animal emulsified in Freund’s incom-
plete adjuvant at week 0, followed by a boost of 100 μg
FMDV15 peptide/animal at week 6. Whole blood sam-
ples were collected by jugular venipuncture from all of
the female F2 and backcross heifers at weeks 0, 1, 2, 4,
8 and 10, post immunisation for IgG analysis (see
below) and at weeks 0, 4, 8 and 10 post immunisation
for T-cell measurements (see below). For the IgG analy-
sis, the blood samples were allowed to clot, and serum
collected and stored at -20°C until they were tested for
the T cell analysis, blood was collected aseptically into
heparin tubes. All experimental protocols were
authorised under the UK Animals (Scientific Proce-
dures) Act, 1986.
Phenotypic Data
Whole blood T-cell Proliferation assay
The T-cell proliferation assay was carried out essentially
as described by Glass et al 1990 [17] with the exception
that whole blood was used. Whole blood (150 μl) was
diluted with 750 μl RPMI 1640 supplemented with
25 mM HEPES, 2 mM glutamine, 10% foetal calf serum,
5 × 10-5 M 2-mercaptoethanol either alone as the nega-
tive control, 10 μg/ml concanavalin A (ConA) (Sigma,
UK) as a positive control or 2.0 μg/ml FMDV15 peptide
(all final concentrations).
Quadruplicate cultures were incubated at 37°C with
5% CO2 for 6 days. For the last 6 hours the cells were
labelled with 0.037MBq3H-Thymidine per well (GE
Healthcare, UK) and uptake assessed by liquid scintilla-
tion counting using a 1450 Microbeta (Wallac, now
PerkinElmer). The results were expressed as counts per
minute of 3H-Thymidine incorporation (mean of
quadruplicates).
ELISA for detection of FMDV15-specific IgG1and IgG2
FMDV15 peptide specific ELISAs were performed to mea-
sure IgG1 and IgG2 isotypes as detailed in Baxter et al
2009 [11]. ELISA tests were conducted on the samples
from all three cohorts, over a short period following the
final sampling, to minimise technical variation. Briefly,
Immunolon 2HB plates (Dynex Technologies) were coated
with 100 μl of 1 μg/ml FMDV15 peptide in carbonate/
bicarbonate buffer (Sigma), serum samples were added at
a dilution predetermined to fit within the standard curve
(see below) concentrations. 100 μl HPR-conjugated sheep
anti bovine IgG1 (Cat. No. A10-116P, pre-optimised at
1/20,000 dilution) or IgG2 (Cat. No.A10-116P, pre-
optimsed at 1/25,000 dilution) (Bethyl Montgomery,
Texas, USA) were added as the secondary antibodies and
colour developed with Sure Blue Reserve tetramethylben-
zidine (TMB) microwell peroxidase substrate 1 compo-
nent (KPL). Optical density was measured at 450 nm on a
Victor2 1420 Multilabel counter (Wallac). Seven serial
dilutions of bovine reference serum (Bethyl), containing
known concentrations of IgG1 and IgG2 in carbonate/
bicarbonate buffer were included on each plate which
enabled the IgG1 and IgG2 concentrations to be calculated
from simple linear regression (Genstat [34]).
Statistical Analysis
Stimulation Indexes (SI) were calculated for the T-cell
proliferation to the FMDV15 peptide (AY) and ConA
(AZ), where SI = AY or Z/Bx and Bx was the negative
control.
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The IgG1 and IgG2 concentrations and the T cell SI
for ConA and FMDV15 were normalised to obtain a
normal distribution and constant variance (log10). Area
under the curve (AUC) for each of these four traits was
also calculated (using the trapezoidal rule [35]) to pro-
vide a single trait that reflected the overall response of
the normalised data.
REML (REsidual Maximum Likelihood) was used,
within Genstat [34], to determine which factors were
significant within the herd. Sex was omitted from the
model as all of the phenotyped animals in this study
were female. The final model included sire and dam as
random effects; the other effects within the model were,
with appropriate degrees of freedom (df), line (F2, CB1,
HB1; 2 d.f) and cohort - corresponding to the 3 years of
the study (1, 2, 3; 2 d.f). Age (age at vaccination; 89 d.f)
and calculated weight (weights of animals at initial vac-
cination date calculated from regression of animal
weights at other time points pre and post vaccination;
193 d.f) were both covariates.
Thus the final REML model was:
Y C W
u g e
jqmanfp j q m a
jqman jqmanf jqmanfp
= + + + +
+ + +
  
Where: Yjqmanfp is the observed value of the phenoty-
pic trait; μ, population mean; bj, the fixed effect of line j
(j = 1, 2, 3); Cq, the fixed effect of cohort q (q = 1,2,3);
gm, the linear covariate of age at vaccination m (m =
d469-d609); Wa, the linear covariate of weight a (a =
361-744 Kg); ujqman, the random effect of sire; gjqmanf,
the random effect of dam; ejqmanfp, the residual error p,
p ~ N(0,Is2p). The residual variance from the model
was used to calculate correlations.
A chi squared test (with 1 df ), using the difference of
the deviance (-2* log likelihood) of the sire and dam,
either in or out of the REML model, was used to calcu-
late the significance of the sire and dam. Wald tests
were used to determine the significance of the other
effects.
Genetic Markers
Standard phenol-chloroform methods were used to
extract DNA from blood samples [36]. A panel of
microsatellite markers were genotyped across all indivi-
duals in the herd, with a total of 165 microsatellite mar-
kers distributed across all 29 autosomes [15]. All of the
genotypes were stored in the database ResSpecies [37]
and used to build linkage maps with CRIMAP 2.4 [38].
The maps were compared to the latest bovine linkage
map [39]. Once compared for consistency, the maps
constructed using CRIMAP, were used to conduct the
QTL analysis for the immune-related traits (Additional
File 4).
QTL Analysis
The 24 traits tested in the QTL analysis were: FMDV15
specific IgG1 and IgG2 concentrations at weeks 0, 1, 2,
4, 8, 10 and AUC; and T-cell proliferation to ConA and
the FMDV15 peptide at weeks 0, 4, 8, 10 and AUC.
GridQTL [40], internet based software, was used for
the QTL analysis. The F2 and backcross module was
used which assumes that founder lines are fixed for
alternative alleles at QTL loci (although they can be seg-
regating at markers) and implements a least squares
analysis. All effects found significant from the previous
analysis using REML were included in the model, thus
for each time point only significant effects were added
to the QTL model. Information content (IC) along the
linkage maps was also calculated by the program. Both
single and two QTL models with additive and domi-
nance effects were fitted at 1 cM intervals along the
autosomes (N = 29), using the sex averaged genetic map
(Additional File 4). By setting the 2 founder breeds as:
breed 1 = Holstein and breed 2 = Charolais, the positive
or negative sign of the additive effects indicated that the
Holstein or Charolais allele, respectively, increased the
trait values. When the dominance effect had the same
sign as the additive effect, this indicated dominance of
the Holstein allele over the Charolais allele, whereas if
the signs of the additive and dominance effects were
opposite, the Charolais allele was dominant.
In total QTL were sought for 24 traits using the 165
microsatellite markers spread across all 29 autosomes of
the bovine genome. Significance thresholds were calcu-
lated by permutation analysis with 1000 permutations
[41]. Four significance levels were used: chromosome-
wide 5% and 1% and genome-wide 5% and 1%.
Refining QTL
The QTL detected at the 5% chromosome-wide signifi-
cance level and above were included in the model and
the genome rescanned for further QTL. By adding the
initial QTL as background effects, the variance caused
by them is removed, thus potentially revealing pre-
viously undetected QTL. In cases where more than one
QTL was found for the same trait on the same chromo-
some, a 2 QTL model was performed by fitting two
QTL simultaneously and re-analysing the data. A for-
ward and backward selection interval mapping approach
was used to check whether QTL moved significantly,
relative to other QTL of the same trait [42], however
none did. These refining methods were repeated, until
no further QTL were detected. Finally, bootstrap analy-
sis was performed, using 1000 repeat samples, for all
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chromosomes where a significant QTL was detected at
the 5% chromosome-wide threshold [43] to estimate the
95% confidence intervals for location of the QTL, except
for the 2 QTL models which were not bootstrapped.
The confidence intervals for 2 QTL models were calcu-
lated by placing one of the QTL in the model to calcu-
late the other QTL’s confidence interval. This would be
repeated with the other QTL and the lower and upper
confidence intervals would be used to set the confidence
interval.
Additional material
Additional file 1: Correlation matrix of traits. Residuals for the REML
model were used to calculate the correlations between each week and
trait. r2 values that are +/- 0.2 are coloured grey and are significant to p
< 0.05
Additional file 2: Factors used in the REML model and their
significance. Only p-values <0.05 are shown for each week for all four
traits. Line was not significant for any trait at any time point.
Additional file 3: Detailed description of QTL located in this study.
Supplementary table showing extra detail of each QTL: 1. Chromosome:
the chromosome number of the QTL. Underlined if 2 QTL model. 2. Trait:
each trait is shown as follows: trait type (IgG1; IgG2; SI_FMDV = T cell
proliferation to the FMDV peptide; SI_CA = T cell proliferation to
Concanavalin A), followed by week post immunisation. 3. cM: the
position the QTL is on the chromosome, in centiMorgans. 4. F: the F-
statistic for each QTL. Significance level: all are at least 5% chromosome
wide, * = p < 1% chromosome wide, **= p < 5% genome wide and
***= p < 1% genome wide. 5. Flanking markers of each QTL peak. 6. The
95% confidence intervals of each QTL. 7. “a” and “d” are the additive and
dominance effect, respectively, of each QTL, * = p < 5%, **= p < 1% and
***= p < 0.01%. 8. “a/SD” and “d/SD” are the standard deviation units for
the additive and dominance effects, respectively.
Additional file 4: Linkage map. Marker distances (cM Kosambi) are
shown for the sex-average maps built for the Charolais × Holstein
population used in this study.
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